Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infectionLeonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (New York, N.Y.)|March 26, 2021
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infectionLeonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Journal of Leukocyte Biology|July 22, 2022
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responsesOne B Dintwe, Stephen C De Rosa, Yunda Huang, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
Scientific Reports|February 9, 2020
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine RegimensXiaoying Shen, Fatima Laher, Zoe Moodie, et al.
NPJ Vaccines|June 26, 2024
A gH/gL-encoding replicon vaccine elicits neutralizing antibodies that protect humanized mice against EBV challengeKristina R Edwards, Harman Malhi, Karina Schmidt, et al.
Nature Communications|June 9, 2023
Persistent serum protein signatures define an inflammatory subcategory of long COVIDAarthi Talla, Suhas V Vasaikar, Gregory Lee Szeto, et al.
Frontiers in Immunology|May 29, 2025
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccinesCassie G Ackerley, Srilatha Edupuganti, Chenchen Yu, et al.
Pageof 8